ReviewGlobal cardiology science & practice2017
The emergence of Kawasaki disease in India and China.
Review in Global cardiology science & practice, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Importance of Fostering International Collaboration for Optimal Outcomes of Kawasaki Disease Worldwide: A Science Advisory From the American Heart Association.Journal of the American Heart Association · 2026Guideline
- Association of ITPKC gene polymorphisms rs28493229 and rs2290692 in North Indian children with Kawasaki disease.Pediatric research · 2022Pooled it
- Clinical outcomes of giant coronary aneurysms in South Asian children with Kawasaki disease.Pediatric rheumatology online journal · 2025Article
- The landscape of inter-institutional and multinational collaborations in Kawasaki disease.Paediatrics & child health · 2025Article
- Clinical & laboratory profiles and treatment outcome of Kawasaki disease in children: Experience from a tertiary care hospital.PloS one · 2025Article
- Long-term health-related quality of life in Kawasaki disease complicated with coronary artery aneurysm in the Nanjing region of China: Results of the largest single-center assessment.Archives of rheumatology · 2024Article
- Incidence of Kawasaki disease among children in Chandigarh, India during 2015-2019: a trend analysis.The Lancet regional health. Southeast Asia · 2024Article
- Application of artificial intelligence in the diagnosis and treatment of Kawasaki disease.World journal of clinical cases · 2024Article
- Relationship between Kawasaki disease and abdominal pain.World journal of clinical cases · 2024Article
- A machine learning model for distinguishing Kawasaki disease from sepsis.Scientific reports · 2023Article
- Association of single nucleotide polymorphism rs113420705 ofJournal of family medicine and primary care · 2022Article
- Profile of Children with Kawasaki Disease Associated with Tropical Infections.Indian journal of pediatrics · 2022Article
- Erythema and Induration of Bacillus Calmette-Guérin Scar Associated With Multisystem Inflammatory Syndrome in Children in Japan: A Case Report.Frontiers in pediatrics · 2022Article
- A global bibliometric analysis on Kawasaki disease research over the last 5 years (2017-2021).Frontiers in public health · 2022Article
- Global epidemiology of vasculitis.Nature reviews. Rheumatology · 2022Review
- Kawasaki Disease- Management Strategies Given Symptoms Overlap to COVID-19: A Review.JNMA; journal of the Nepal Medical Association · 2021Review
- Platelets in Kawasaki disease: Is this only a numbers game or something beyond?Genes & diseases · 2020Review
- Kawasaki Disease: Global Burden and Genetic Background.Cardiology research · 2020Review
- The Platelet microRNA Profile of Kawasaki Disease: Identification of Novel Diagnostic Biomarkers.BioMed research international · 2020Article
- Facial nerve palsy presenting as rare neurological complication of Kawasaki disease: A case report.Medicine · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Kawasaki disease (KD) is recognized as a leading cause of acquired heart disease in children in developed countries. Although global in distribution, Japan records the highest incidence of KD in the world. Epidemiological reports from the two most populous countries in the world, namely China and India, indicate that KD is now being increasingly recognized. Whether this increased reporting is due to increased ascertainment, or is due to a true increase in incidence, remains a matter of conjecture. The diagnosis and management of KD in developing countries is a challenging proposition. In this review we highlight some of the difficulties faced by physicians in managing children with KD in resource-constrained settings.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.